VASEXTEN

This brand name is authorized in Netherlands

Active ingredients

The drug VASEXTEN contains one active pharmaceutical ingredient (API):

1 Barnidipine UNII 7LZ6R3AEM1 - BARNIDIPINE HYDROCHLORIDE

Barnidipine is a lipophilic 1,4-dihydropyridine calcium antagonist showing high affinity for the calcium channels of the smooth muscle cells in the vascular wall. Read about Barnidipine

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
VASEXTEN Modified release capsules	European Medicines Agency (EU)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
C08CA12	Barnidipine	C Cardiovascular system → C08 Calcium channel blockers → C08C Selective calcium channel blockers with mainly vascular effects → C08CA Dihydropyridine derivatives
Discover more medicines within C08CA12

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 55352, 55360